- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05251519
The Efficacy of Derotation Banding on Outcome Measures in Children With Cerebral Palsy
August 27, 2022 updated by: Fatih Ozden, Muğla Sıtkı Koçman University
The Efficacy of Derotation Taping on Balance, Performance, Gait, Spasticity and Quality of Life in Femoral Internal Rotation Deformity in Children With Cerebral Palsy
The aim of the study is to compare the conventional rehabilitation program and derotation taping applied with Kinesio Tex tape in addition to conventional rehabilitation in children with hemiplegic or monoplegic cerebral palsy with femoral internal rotation deformity.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Conventional rehabilitation (CR) practices will be applied to the control group.
Conventional rehabilitation (KT) application will be applied to the study group in addition to Kinesio Tex tape derotation banding.
With the kinesio tape application, it is aimed to provide economical, ergonomic and effective support to the patients in non-clinical times.
It is aimed to evaluate the patients' balance, quality of life, performance test, spasticity level and gait quality.
Study Type
Interventional
Enrollment (Actual)
32
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Fethiye
-
Muğla, Fethiye, Turkey, 48300
- Fethiye Private Son Atılım Special Education and Rehabilitation Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
4 years to 12 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Children with cerebral palsy aged 4-12 years with unilateral involvement who are hemiplegic or monoplegic
- Cases with Gross Motor Function Classification (GMFCS) level 1 or 2
- Understanding simple commands and signing the consent form
Exclusion Criteria:
- Presence of a static cause of femoral internal rotation deformity
- Situations that may prevent assessments or communication
- Lack of cooperation during work
- Presence of surgery that may affect assessments, such as joint freezing
- Presence of botulinum toxin administration in the last 6 months
- Development of an allergic reaction on the skin to the tape
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Kinesio Taping Group (KTG)
Conventional rehabilitation application will be performed in addition to Kinesio Tex tape derotation taping.
|
Derotation taping with Kinesio Tex is applied to the patients through a pediatric physiotherapist.
|
|
Active Comparator: Conventional Rehabilitation Group (CRG)
A conventional rehabilitation program will be applied to the patients through a pediatric physiotherapist.
|
Conventional rehabilitation program is applied to the patients through a pediatric physiotherapist
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
6MWT
Time Frame: Change from Baseline 6MWT at 3 days
|
The 6-meter course was mapped as 10 meters in length with a 2-meter acceleration interval and a 6-meter testing interval.
There is no scoring range for the 6MWT.
|
Change from Baseline 6MWT at 3 days
|
|
PBBT
Time Frame: Change from Baseline PBBT at 3 days
|
PBBT is a 14-item, criterion-referenced measure and examines functional balance in the context of everyday tasks.
PBBT is scored between 0 to 56.
Higher scores indicate better function.
|
Change from Baseline PBBT at 3 days
|
|
MAS
Time Frame: Change from Baseline MAS at 3 days
|
The Modified Ashworth Scale is a 6-point rating scale for gauging muscle resistance to passive movement.
MAS is scored from 0 to 4, where lower scores represent normal muscle tone and higher scores represent spasticity.
|
Change from Baseline MAS at 3 days
|
|
EVGS
Time Frame: Change from Baseline EVGS at 3 days
|
EVGS was developed to evaluate gait in children with CP using video recordings.
It includes 17 variables, and each of these variables can be scored as 0, 1, or 2 based on movement deviation from normal.
enced measure and examines functional balance in the context of everyday tasks.
EVGS is scored between 0 to 34.
Higher scores indicate worse gait function.
|
Change from Baseline EVGS at 3 days
|
|
KINDL
Time Frame: Change from Baseline KINDL at 3 days
|
The KINDL was derived from a conceptual model, in which the four main components of quality of life, namely psychological well-being, social relationships, physical function and everyday life activities, were included in interviews with children.
KINDL is scored between 0 to 100.
Higher scores indicate better quality of life.
|
Change from Baseline KINDL at 3 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: İsmet Tümtürk, BSc, Ege University
- Principal Investigator: Ahmet İmerci, PhD, Muğla Sıtkı Koçman University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 15, 2022
Primary Completion (Actual)
August 15, 2022
Study Completion (Actual)
August 26, 2022
Study Registration Dates
First Submitted
January 31, 2022
First Submitted That Met QC Criteria
February 13, 2022
First Posted (Actual)
February 22, 2022
Study Record Updates
Last Update Posted (Actual)
August 31, 2022
Last Update Submitted That Met QC Criteria
August 27, 2022
Last Verified
August 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CPKT1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.